Compare PTCT & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | PJT |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | 991 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.4B |
| IPO Year | 2006 | 2015 |
| Metric | PTCT | PJT |
|---|---|---|
| Price | $63.29 | $150.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 4 |
| Target Price | $80.65 | ★ $178.50 |
| AVG Volume (30 Days) | ★ 918.2K | 319.3K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | $264,734,000.00 | ★ $1,713,671,000.00 |
| Revenue This Year | N/A | $11.12 |
| Revenue Next Year | $17.70 | $9.98 |
| P/E Ratio | $69.20 | ★ $23.03 |
| Revenue Growth | ★ 36.19 | 14.77 |
| 52 Week Low | $58.90 | $127.73 |
| 52 Week High | $90.87 | $195.62 |
| Indicator | PTCT | PJT |
|---|---|---|
| Relative Strength Index (RSI) | 34.72 | 31.10 |
| Support Level | N/A | $144.58 |
| Resistance Level | $68.93 | $163.37 |
| Average True Range (ATR) | 1.97 | 5.24 |
| MACD | -0.32 | -1.89 |
| Stochastic Oscillator | 22.43 | 15.37 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services, and others. Geographically, it generates maximum revenue from the United States, followed by the United Kingdom and other markets.